72 related articles for article (PubMed ID: 1006134)
21. Hormones and obesity: changes in insulin and growth hormone secretion following surgically induced weight loss.
Crockford PM; Salmon PA
Can Med Assoc J; 1970 Jul; 103(2):147-50. PubMed ID: 5430052
[TBL] [Abstract][Full Text] [Related]
22. The effects on insulin action in adult hypopituitarism of recombinant human GH therapy individually titrated for six months.
McConnell EM; Atkinson AB; Ennis C; Hadden DR; McCance DR; Sheridan B; Bell PM
J Clin Endocrinol Metab; 2001 Nov; 86(11):5342-7. PubMed ID: 11701703
[TBL] [Abstract][Full Text] [Related]
23. Effect of growth hormone on acute glucagon and insulin release.
Sirek A; Vranic M; Sirek OV; Vigas M; Policova Z
Am J Physiol; 1979 Aug; 237(2):E107-12. PubMed ID: 380363
[TBL] [Abstract][Full Text] [Related]
24. Metabolic changes and vascular risk factors in hypopituitarism.
Johnston DG; Beshyah SA; Markussis V; Shahi M; Sharp PS; Foale RA; Skinner EM
Horm Res; 1992; 38 Suppl 1():68-72. PubMed ID: 1295816
[TBL] [Abstract][Full Text] [Related]
25. Epinephrine deficiency in hypocorticotropic hypopituitary children.
Rudman D; Moffitt SD; Fernhoff PM; Blackston RD; Faraj BA
J Clin Endocrinol Metab; 1981 Oct; 53(4):722-9. PubMed ID: 6270172
[TBL] [Abstract][Full Text] [Related]
26. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.
Laursen T; Jørgensen JO; Jakobsen G; Hansen BL; Christiansen JS
J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114
[TBL] [Abstract][Full Text] [Related]
27. Effect of growth hormone-releasing factor on plasma growth hormone, prolactin and somatomedin C in hypopituitary and short normal children.
Van Vliet G; Bosson D; Robyn C; Craen M; Malvaux P; Vanderschueren-Lodeweyckx M; Wolter R
Horm Res; 1985; 22(1-2):32-45. PubMed ID: 3928475
[TBL] [Abstract][Full Text] [Related]
28. Effects of 7 years of growth hormone replacement therapy in hypopituitary adults.
Chrisoulidou A; Beshyah SA; Rutherford O; Spinks TJ; Mayet J; Kyd P; Anyaoku V; Haida A; Ariff B; Murphy M; Thomas E; Robinson S; Foale R; Johnston DG
J Clin Endocrinol Metab; 2000 Oct; 85(10):3762-9. PubMed ID: 11061536
[TBL] [Abstract][Full Text] [Related]
29. Effect of oral contraceptive containing a new progestin (ORG 2969) on plasma renin activity, growth hormone and immunoreactive insulin.
Liukko P; Erkkola R; Lammintausta R
Ann Chir Gynaecol; 1979; 68(5-6):155-9. PubMed ID: 161858
[TBL] [Abstract][Full Text] [Related]
30. [Sensitivity to exogenous insulin and the efficiency and release of endogenous insulin in subjects with non-hypoglycemic hypopituitarism treated with growth hormone].
Cacciari E; Sarti E; Cicognani A; Pirazzoli P; Salardi S; Mazzanti L; Bernardi F; Zappulla F; Cassio A
Minerva Pediatr; 1980 Jan; 32(1):15-21. PubMed ID: 7019661
[No Abstract] [Full Text] [Related]
31. Effects of systemic growth hormone (GH) administration on regional adipose tissue distribution and metabolism in GH-deficient children.
Rosenbaum M; Gertner JM; Leibel RL
J Clin Endocrinol Metab; 1989 Dec; 69(6):1274-81. PubMed ID: 2685009
[TBL] [Abstract][Full Text] [Related]
32. [Low sensitivity of IGF-I, IGFBP-3 and urinary GH in the diagnosis of growth hormone insufficiency in slowly-growing short-statured boys. Grupo Español de Estudio de la Talla Baja].
Audí L; Antonia Llopis M; Luisa Granada M; Hermoso F; del Valle J; Dolores Rodríguez-Arnao M; Bel J; Luzuriaga C; Gallego E; Marín F;
Med Clin (Barc); 2001 Jan; 116(1):6-11. PubMed ID: 11181253
[TBL] [Abstract][Full Text] [Related]
33. Growth hormone release by glycine injected intravenously in 22 healthy sexually immature children.
Popa M; Florea I
Biomedicine; 1975 Apr; 23(4):131-3. PubMed ID: 1222231
[TBL] [Abstract][Full Text] [Related]
34. Coronary flow reserve is impaired in patients with adult growth hormone (GH) deficiency.
Oflaz H; Sen F; Elitok A; Cimen AO; Onur I; Kasikcioglu E; Korkmaz S; Demirturk M; Kutluturk F; Pamukcu B; Ozbey N
Clin Endocrinol (Oxf); 2007 Apr; 66(4):524-9. PubMed ID: 17371470
[TBL] [Abstract][Full Text] [Related]
35. The effect of combined administration of L-proline and glycine on GH and IRI release in healthy prepuberal children.
Popa M; Florea I; Simionescu L; Dinulescu E; Bartoc R; Dimitriu V; Juvină E
Endocrinologie; 1979; 17(3):201-4. PubMed ID: 504961
[TBL] [Abstract][Full Text] [Related]
36. High serum sex hormone-binding globulin (SHBG) and low serum non-SHBG-bound testosterone in boys with idiopathic hypopituitarism: effect of recombinant human growth hormone treatment.
Belgorosky A; Martinez A; Domene H; Heinrich JJ; Bergada C; Rivarola MA
J Clin Endocrinol Metab; 1987 Dec; 65(6):1107-11. PubMed ID: 3680477
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the acute metabolic effects of 22,000-dalton and 20,000-dalton growth hormone in human subjects.
Culler FL; Kaufmann S; Frigeri LG; Jones KL
Horm Metab Res; 1988 Feb; 20(2):107-9. PubMed ID: 3286449
[TBL] [Abstract][Full Text] [Related]
38. The effect of 3 months of recombinant human growth hormone (GH) therapy on insulin and glucose-mediated glucose disposal and insulin secretion in GH-deficient adults: a minimal model analysis.
O'Neal DN; Kalfas A; Dunning PL; Christopher MJ; Sawyer SD; Ward GM; Alford FP
J Clin Endocrinol Metab; 1994 Oct; 79(4):975-83. PubMed ID: 7962308
[TBL] [Abstract][Full Text] [Related]
39. The effect of 24 months recombinant human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo [a] in hypopituitary adults previously treated with conventional replacement therapy.
O'Neal DN; Hew FL; Best JD; Alford F
Growth Horm IGF Res; 1999 Jun; 9(3):165-73. PubMed ID: 10502452
[TBL] [Abstract][Full Text] [Related]
40. The growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, in short normal and obese children and in hypopituitary subjects.
Loche S; Cambiaso P; Carta D; Setzu S; Imbimbo BP; Borrelli P; Pintor C; Cappa M
J Clin Endocrinol Metab; 1995 Feb; 80(2):674-8. PubMed ID: 7852535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
